EMFACE vs Dermal Fillers: Which May Suit Facial Lifting, Definition or Volume Loss?

Clinical guidance from Dr Nyla Raja MBChB (Hons), MRCGP (Dist), DFFP, DPDermatology - GMC No. 6057913

EMFACE and dermal fillers can both support a fresher, more defined appearance, but they work in fundamentally different ways. EMFACE is a needle-free treatment that targets facial muscle tone and skin firmness. Dermal fillers are injectable treatments that restore or enhance volume and can refine facial contours.

For many people, the choice comes down to the cause of the concern. If the face appears less lifted because of early skin laxity or reduced muscular support, EMFACE may be worth considering. If hollowing, loss of cheek structure, a less defined chin or jawline, or deeper static folds are the main concern, dermal fillers may be more relevant. They are not direct substitutes, and in some cases neither treatment is the right option.

At Dr Nyla Medispa, treatment selection begins with an in-person medical assessment of facial anatomy, skin quality, muscle tone, volume distribution, proportions, medical history, and the change you would like to achieve.

The key difference: muscle and skin support versus volume

Facial ageing is multi-layered. Skin may become less firm, facial fat compartments and deeper structural support can change, and the muscles that contribute to expression and facial position may lose tone. A treatment that addresses one layer cannot necessarily correct another.

EMFACE combines synchronised radiofrequency with High-Intensity Facial Electrical Stimulation (HIFES™). The radiofrequency component is designed to heat the dermis, while the electrical stimulation produces repeated contractions in selected facial muscles. It is a non-invasive approach intended to improve facial tone, skin firmness, and the appearance of wrinkles gradually.

Dermal fillers, usually made from hyaluronic acid, are placed beneath the skin in carefully selected areas to restore volume, support contours, or improve proportion. They can be used, for example, for cheeks, temples, lips, the chin, jawline, tear troughs, and selected lines and folds. Their effect is principally structural: filler does not strengthen facial muscles or tighten loose skin in the way an energy-based treatment aims to do.

When EMFACE may be the better fit

EMFACE may suit someone who would prefer a non-invasive treatment and is concerned by early-to-moderate laxity, a reduction in facial tone, fine lines, or a subtly less lifted appearance. It may also appeal to patients who do not want injections, anaesthetic, or recovery time.

Changes are expected to be progressive rather than immediate. A small histological study of synchronised radiofrequency and facial electrical stimulation found changes in collagen and elastin markers after a four-treatment course, but its sample size was very limited. This is useful early evidence, rather than a guarantee of a particular result for every patient. The published study also reflects why EMFACE should be viewed as a treatment for gradual refinement, not a replacement for volume restoration or surgery.

More recent clinical research has reported improvements in midface muscle thickness, skin displacement, and facial volume measurements after a course of combined HIFES and radiofrequency. However, the study was non-randomised, so individual response, baseline anatomy, and realistic expectations remain important. Read the study abstract.

When dermal fillers may be the better fit

Dermal fillers may be more appropriate where the visible issue is structural volume loss or insufficient definition. Typical examples include hollow cheeks or temples, a recessed or less projected chin, reduced jawline definition, lip volume loss, or facial folds made more noticeable by changes in the tissues that support the face.

Because fillers physically add support or volume, results are usually visible at the appointment, although the final appearance should be judged after initial swelling has settled. At Dr Nyla Medispa, filler treatment is planned across the face as a whole rather than treating an isolated line in isolation.

Longevity varies with the product, placement, amount used, metabolism, and individual factors. Results may last for several months or longer, depending on the treatment area and product selected. Fillers can be adjusted over time, but more product is not always the answer: treating facial balance and avoiding unnecessary volume are central to a natural-looking outcome.

Can EMFACE and dermal fillers be combined?

They can be complementary when assessment identifies different concerns at different tissue levels. For example, EMFACE may be considered for gradual improvement in facial tone and skin firmness, while small, considered amounts of filler may address a specific area of volume loss or contour deficiency.

Combination treatment is not automatically better. The order, spacing, and appropriateness of treatments should be individualised. Some people achieve their preferred outcome with one approach; others may be advised to wait and reassess before adding another treatment.

Safety and recovery: important practical differences

EMFACE does not involve injections, and patients can usually return to normal activities immediately. During treatment, it is normal to feel warmth from radiofrequency and rhythmic contractions from the muscle stimulation. Suitability still needs to be assessed, particularly where there is an implanted electronic device, metal in the treatment area, pregnancy, or another relevant medical consideration.

With dermal fillers, mild swelling, tenderness, redness, and bruising are common short-term effects. Hyaluronic acid fillers have an established role in aesthetic medicine, but injections require detailed knowledge of facial anatomy and appropriate complication preparedness. Serious complications, including vascular occlusion, are uncommon but clinically important, which is why practitioner training, patient selection, and prompt assessment of unexpected pain, blanching, or visual symptoms matter. Clinical guidance on filler-related vascular occlusion explains the need for rapid recognition and management.

Patients should disclose previous filler, medical conditions, allergies, medicines, dental treatment plans, and any history of cold sores where relevant. A consultation is also an opportunity to discuss whether delaying treatment, treating the skin first, or considering a surgical opinion would better match the concern.

When neither treatment may be the answer

Neither EMFACE nor fillers can reproduce the correction achieved by facelift surgery where there is marked skin excess, significant tissue descent, or a degree of laxity beyond what non-surgical treatment can realistically address. Similarly, filler is not appropriate simply because a line is visible: if the underlying issue is skin quality, facial movement, or advanced laxity, adding volume may not improve the result.

A new, sudden, asymmetrical change in the face, persistent swelling, pain, or another unexplained symptom should be medically assessed rather than assumed to be an aesthetic concern.

The key point

EMFACE may be considered where the priority is a needle-free, gradual improvement in facial muscle tone, skin firmness, and early lifting concerns. Dermal fillers may be more relevant where the priority is restoring lost volume, improving contour, or refining facial proportions. The most suitable option depends less on which treatment is more popular and more on what is causing the change you see in the mirror.